Trials / Completed
CompletedNCT03634566
Effect of N_Acetylcysteine on Liver Functions in Donors in Living Liver Transplantation
Effect of N_Acetylcysteine on Liver Functions in Donors in Living Donor Liver Transplantation
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
our practice for the past 10 years we have noticed a transitional impairment of liver function (elevated liver enzymes, total and direct bilirubin, and elevated serum lactate levels) following donors' liver resection. Several drugs have been investigation on liver regeneration , proven benefit of N-Acetylcysteine (NAC) on rats with steatohpatitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-Acetylecysteine | N-Acetylecysteine 150 mg/kg diluted in 100 ml glucose 5 % over 40 minutes followed by NAC 12.5 mg/kg in 500 ml glucose 5% over 4 hours, followed by NAC 6.25 mg/kg for 2 postoperative days |
| DRUG | Placebo | Ringer acetate continuous infusion at the same rate for 2 days. |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2019-02-01
- Completion
- 2019-04-01
- First posted
- 2018-08-16
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03634566. Inclusion in this directory is not an endorsement.